期刊档案

European Medical Journal Urology

ISSN 2053-4213 · European Medical Journal · United Kingdom

European Medical Journal Urology 钻石开放获取(无 APC),免版面费,投稿社区反馈审稿约 17 周,2025 年发文 23 篇。

影响因子—暂无公布值
中科院分区—未被分区表收录
CiteScore 分区—暂无 CiteScore 排名
审稿周期约 17 周投稿社区平均反馈
版面费免版面费钻石开放获取(无 APC)
录用比例—暂无反馈
年发文量23 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

European Medical Journal Urology 由 European Medical Journal 出版。按 OpenAlex 近年发文统计,该刊主要发表 Urinary Bladder and Prostate Research、Prostate Cancer Diagnosis and Treatment、Bladder and Urothelial Cancer Treatments 等主题的论文,这 3 个主题约占 37.3%,主导子领域为 Pulmonary and Respiratory Medicine。(根据 OpenAlex 主题统计与中科院分区数据生成)

EMJ Urology is an open access, peer-reviewed eJournal committed to helping elevate the quality of healthcare in urology by publishing content on all aspects of urological function and disease. The journal is published annually, six weeks after the European Association of Urology (EAU) Congress, and features highlights from this congress, alongside interviews with experts in the field, reviews of abstracts presented at the congress, as well as in-depth features on congress sessions. Additionally, this journal covers advances within the clinical and pharmaceutical arenas by publishing sponsored content from congress symposia, which is of high educational value for healthcare professionals. This undergoes rigorous quality control checks by independent experts and the in-house editorial team. EMJ Urology also publishes peer-reviewed research papers, review articles, and case reports in the field. In addition, the journal welcomes the submission of features and opinion pieces intended to create a discussion around key topics in the field and broaden readers’ professional interests. EMJ Urology is managed by a dedicated editorial team that adheres to a rigorous double-blind peer-review process, maintains high standards of copy editing, and ensures timely publication. Our focus is on research that is relevant to all healthcare professionals. We do not publish veterinary science papers or laboratory studies not linked to patient outcomes. We have a particular interest in topical studies that advance research and inform of coming trends affecting clinical practice in Urology. Topics include (but are not limited to): Prostate cancer Bladder cancer Renal cell carcinoma Radical cystectomy Tissue engineering in Urology 3D guidance for renal/kidney stone management Robot-assisted partial nephrectomy in renal cell carcinoma Neuro-urology Geriatrics and older adult urology Women’s health in urology Surgical options for functional urology Targeting/personalised treatment of bladder cancer Peyronie’s disease Surgical training in urology Antibiotic prophylaxis in prostate biopsy Robotic surgery Paediatric urology Reconstructive urology UTI treatment Urinary stones Use and risk of ureteroscopy Urothelial cancer Imaging in urology Biomarkers in urology Phalloplasty Regenerative urology

摘自期刊官网 Aims & Scope

主编 Abdullah Erdem出版商官网

编委会国家分布:未见中国大陆编委;主要国家 美国 2、土耳其 2、英国 1、意大利 1、澳大利亚 1(共 9 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Urinary Bladder and Prostate ResearchMedicine17.1%
  2. Prostate Cancer Diagnosis and TreatmentMedicine12.9%
  3. Bladder and Urothelial Cancer TreatmentsMedicine7.3%
  4. Urological Disorders and TreatmentsMedicine7.1%
  5. Prostate Cancer Treatment and ResearchMedicine6.5%
  6. Kidney Stones and Urolithiasis TreatmentsMedicine6.5%
  7. Urinary and Genital Oncology StudiesMedicine5%
  8. Ureteral procedures and complicationsMedicine4.8%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)未收录

该期刊未被此版本分区表收录。

《新锐期刊分区表》( 2026年3月发布)未收录

该期刊未被此版本分区表收录。

期刊分区表( 2023年12月旧的升级版)未收录

该期刊未被此版本分区表收录。

数据库收录

DOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

期刊官网自述收录

Google Scholar出版商官网

期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

h-index
7OpenAlex ·
i10-index
3OpenAlex ·
两年平均被引
0.16OpenAlex ·
Gold OA 文章占比
0%LetPub ·

逐年发文量 OpenAlex 统计 · 累计 200 篇 · 当年数据不完整

年份发文量其中 OA被引
2026232321
2025232321
2024171728
2023181834
2022212128
20216620

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

平均审稿速度(社区反馈)
17 WeeksLetPub ·
投稿到发表(期刊自报)
约 17 周DOAJ ·
评审方式
双盲同行评审DOAJ

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

钻石开放获取(无 APC)DOAJ

所有文章开放获取,且不向作者收取文章处理费。

来源文章处理费费用减免许可证观测时间
DOAJ无文章处理费无CC BY-NC
LetPub无文章处理费无—
出版商官网无文章处理费——

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

投稿准备要点3 项,摘自作者指南
关键词
3–10 个
参考文献格式
顺序编码制(按引用顺序编号)
投稿信(Cover letter)
必须提供
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型12 种
  1. case reportOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
  2. case reportsCase reports (abstract: unstructured, ≤250 words; main text: <3,000 words +/-10%; maximum of 3 tables or figures; maximum 60 references +/-10%).未说明篇幅
  3. editorialThe Editorial Staff will evaluate disclosed conflicts to determine if they are significant enough to preclude publication or require additional scrutiny. Review…未说明篇幅
  4. literature reviewOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
  5. meta-analysisOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
  6. narrative reviewOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
  7. original researchOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
  8. perspectiveOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
  9. reviewOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
  10. review articleOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
  11. review articlesReview articles (abstract: unstructured [unless a systematic review], ≤250 words; main text: <3,000 words +/-10%; maximum of 3 tables or figures; maximum 60 ref…未说明篇幅
  12. systematic reviewOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
出版商官网
官网政策摘录作者资格、利益冲突、出版伦理、许可与版权、开放获取、同行评审、查重
作者资格 Authorship

作者身份意味着对已发表工作承担责任并体现研究者的贡献;署名分配给对研究的分析与解释有贡献但可能未参与研究构思与设计的个人,每位作者的贡献与责任均应写明,未达到署名标准的其他贡献者(如教授)可在致谢中说明。 模型中文摘要

Authorship implies responsibility and accountability for published work as well as providing credit for a researcher’s contributions to a study. Assignment of authorship is to individuals who have contributed to the analysis and interpretation of a study but who may not have contributed to its conception and design. The contribution and responsibility of every author should be included. Authors ma…

原文 ↗出版商官网 ·
利益冲突 Disclosure and Conflicts of Interest

当对稿件的专业判断可能受次要利益(如经济利益)影响时即存在利益冲突,例如须披露作者(或其近亲)受雇、签约、提供服务或以其他方式合作的任何制药、生物制剂、医疗器械和诊断公司的名称及关系。 模型中文摘要

A conflict of interest can be said to exist when professional judgement concerning the manuscript may be influenced by a secondary interest (e.g., financial gain). For example, this would include disclosing the names of (and relationship with) any pharmaceutical, biologics, medical device, and diagnostic companies for which an author (or one of their close family members) is employed, contracted f…

原文 ↗出版商官网 ·
出版伦理 Ethical Approval

开展医学研究的所有作者应遵循《赫尔辛基宣言》;研究类文章的作者应能应要求提交机构审查委员会或伦理委员会批准研究的声明,并应尽力保护患者隐私与匿名,仅在关键且不可避免时才纳入可能识别身份的信息。 模型中文摘要

We expect that all authors conducting medical research follow the Declaration of Helsinki, which can be viewed here: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. Research articles: Authors should be able to submit, upon request, a statement from their institutional review board or ethics committee indicating approv…

原文 ↗出版商官网 ·
许可与版权 Copyright

版权是赋予作品创作者的法律权利,适用于文学、戏剧、音乐、艺术、录音、影片、广播及有线节目和已出版版本的版式编排等;作者通常涉及图表或照片的版权,若在稿件中使用非本人创作的图像且未经版权持有人同意,复制、改编、出租出借或公开表演等行为均属违法。 模型中文摘要

Copyright is the legal right given to the creator of a piece of work. The types of work to which copyright applies include literary, dramatic, musical, artistic, sound recording, films, broadcasts and cable programmes, and typographical arrangement of published editions. Usually for authors copyrighted material will be figures, tables or photos. If you want to include an image in your manuscript t…

原文 ↗出版商官网 ·
开放获取 Open Access

本刊为开放获取期刊,采用知识共享署名-非商业性使用4.0(CC BY-NC 4.0)许可,允许用户以任何媒介或格式复制并再分发材料、对材料进行混合、转换和在此基础上创作,但须给予适当署名、提供许可链接并注明是否作了修改,且不得将材料用于商业目的。 模型中文摘要

We are an open-access journal in accordance with the Creative Commons Attribution-Non Commercial 4.0 (CC BY-NC 4.0)< license. This permits users to: Share – Copy and redistribute the material in any medium or format. Adapt – Remix, transform, and build upon the material. Under the following terms: Attribution – You must give appropriate credit, provide a link to the license, and indicate if change…

原文 ↗出版商官网 ·
同行评审 Peer Review Process

所有投稿先由编辑团队初审,质量不高、不符合指南或超出期刊范围的文章可在同行评审前被拒;通过初审的稿件将送至少两名独立审稿人进行双盲同行评审,稿件将根据同行评审反馈、作者修改的配合程度及编辑的最终选择决定是否发表。 模型中文摘要

All submissions are initially reviewed by the Editorial team. At this stage, papers may be rejected before peer review if we feel that they are not of high enough quality, do not follow our guidelines, or are not within the scope of the journal. This ensures that authors are given a quick decision if their paper is unsuitable. Papers that pass the initial review process will be sent out for peer r…

原文 ↗出版商官网 ·
查重 Policy on Plagiarism

向EMJ投稿即表示稿件为原创、未发表且未同时投给其他刊物;数据造假或捏造、抄袭(包括未恰当引用而重复发表作者本人作品)及盗用他人成果均不可接受,经Kriyadocs平台提交的稿件将进行抄袭筛查,相关学术不端将按COPE指南严肃处理。 模型中文摘要

By submitting your manuscript to the EMJ it is understood that it is an original manuscript, is unpublished work and is not under consideration elsewhere. Falsification or fabrication of data, plagiarism, including duplicate publication of the authors’ own work without proper citation, and misappropriation of the work are all unacceptable practices. All manuscripts submitted to EMJ via the Kriyado…

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
European Medical Journal
出版国家或地区
United Kingdom
出版语言
English
ISSN
2053-4213
官方链接

常见问题

关于 European Medical Journal Urology 的常见问题

European Medical Journal Urology 的审稿周期多长?

投稿社区反馈的平均审稿速度为约 17 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

European Medical Journal Urology 的投稿格式要求是什么?

据期刊作者指南:关键词:3–10 个;参考文献格式:顺序编码制(按引用顺序编号);投稿信:必须提供。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。

European Medical Journal Urology 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 9 位编委中,没有中国大陆学者;人数最多的国家是 美国(2 位)、土耳其(2 位)、英国(1 位)。统计按编委会页面列出的机构国家计,仅供参考。

European Medical Journal Urology 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,European Medical Journal Urology 被 DOAJ 收录。

European Medical Journal Urology 是开放获取期刊吗?版面费多少?

European Medical Journal Urology 为钻石开放获取(无 APC)。不收取文章处理费。

来源与更新

本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-25 归档)。最近更新:。